DiaTech Oncology Files Patents for Drug Discovery

DiaTech MiCK Assay technology provides a new strategy to shorten development time for Drug Discovery process
NASHVILLE, Tenn., Sept. 7, 2010 — DiaTech Oncology has announced the filing of a patent for Drug Discovery that will provide a new strategy and approach to validate drugs that may be more e…

Pisgah Labs, Inc. Tackles Prescription Drug Abuse As It Files Eighth Patent

PISGAH FOREST, N.C., Jan. 12, 2010 — According to the Office of National Drug Control Policy (http://www.whitehousedrugpolicy.gov), prescription drug abuse is more prevalent than abuse of cocaine, heroin and methamphetamine. In fact, in the past year, prescription drug abuse ranked second…

Botox Cosmetic Gets a New Wrinkle; Crutchfield Dermatology of Eagan, Minnesota Performs the First Dysport(TM) (aboBotulinum-A) Treatment in the United States

EAGAN, Minn., Oct. 26, 2009 — The story: Dysport(TM), a new wrinkle fighter, is now available in the United States. Dysport(TM) is a Botulinum-A enzyme like Botox Cosmetic. Dysport(TM) is positioned as the new arch-nemesis and first direct competitor of Botox Cosmetic in the United States. Dysp…